This is potentially great news from DR. Frits van Rhee and other researchers at UAMS, focusing on ways to attack high risk multiple myeloma:
“There are currently no good drugs available to tackle the high-risk disease,” said Frits van Rhee, M.D., Ph.D., who leads immunology research at the Myeloma Institute. “We can get patients into remission, but the duration of remission is brief, so they relapse fast and overall survival is short.”
Now, after years of research with immune cells, van Rhee is on the verge of a breakthrough that could save patients from the deadliest forms of myeloma. The research involves natural killer cells, and clinical trials could begin by the end of the year.
I’m actually quite positive that this will be effective,” said van Rhee, who joined UAMS in 2000. “I am excited. There’s been a lot of work that has been going on for quite a few years.”
Read the article, Natural Born Killers, that one of our readers named Patrizia, found on the UAMS Health.com Website. Interesting stuff.
There is a lot of ongoing research focusing on using “killer cells” to fight many different forms of cancer. Still just a hopeful, exciting theory. But hopeful is good, right?
Feel good and keep smiling! Pat